Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Interaction Between Non-Insuli...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Interaction Between Non-Insulin Glucose-Lowering Medication and Exercise in Type 2 Diabetes Mellitus – New Findings on SGLT2 Inhibitors

Interaction Between Non-Insulin Glucose-Lowering Medication and Exercise in Type 2 Diabetes Mellitus – New Findings on SGLT2 Inhibitors

Bibliographic Details
Main Author: Christian Brinkmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Endocrinology
Subjects:
exercise
training
medication
SGLT2 inhibitor
metformin
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.694099/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.694099/full

Similar Items

  • SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2
    by: Ying Zhou, et al.
    Published: (2019-01-01)
  • Peripheral combination treatment of leptin and an SGLT2 inhibitor improved glucose metabolism in insulin-dependent diabetes mellitus mice
    by: Hiroshi Yaginuma, et al.
    Published: (2021-12-01)
  • Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
    by: Tamara Y. Milder, et al.
    Published: (2019-01-01)
  • SGLT2 inhibitors for treatment of Type 2 diabetes mellitus: Focus on Canagliflozin
    by: Santosh Kumar Singh, et al.
    Published: (2014-01-01)
  • The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition
    by: Muhammad Saad, et al.
    Published: (2018-11-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...